✦ LIBER ✦

Efficacy and tolerability of infliximab therapy in pediatric IBD: A retrospective single center experience

✍ Scribed by Russo, M.; Martinelli, M.; Alessandrella, A.; Crocetto, F.; Mancusi, V.; Andreozzi, M.L.; Staiano, A.; Miele, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P106 CLINICAL BENEFITS AND PATTERN OF IN

✍ M.K. Sladek; A. Swiat; S. Pieczarkowski; K. Fyderek 📂 Article 📅 2009 🏛 Oxford University Press ⚖ 51 KB

PP12 INFLIXIMAB IN THE TREATMENT OF PEDI

✍ S. Accomando; C. Albino; C. Zicari; A. Liotta; G. Corsello 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Efficacy, tolerability, and predictors o

✍ Michael B. Sprakes; Alexander C. Ford; Lisa Warren; Dan Greer; John Hamlin 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 730 KB

PP12 EFFICACY OF INFLIXIMAB IN REDUCING

✍ S. Accomando; C. Albino; M. Bonanno; F. Scavuzzo; C. Zicari; G. Corsello 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

N002 Tolerability of shortened one-hour

✍ Guidi, L.; Marzo, M.; Donati, A.; Ennas, S.; Pugliese, D.; Felice, C.; Andrisani 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 63 KB

Clinical Correlates of Infliximab (IFX)

✍ Felipez, Lina M. ;Gokhale, Ranjana ;Wroblewski, Kristen ;Godick, Anna ;Kirschner 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 95 KB